We are extremely pleased and enthusiastic that we can count upon the valued support of Business Angels Marne-Ardennes (BAMA, former Reims Business Angels)!
This enables Apmonia Therapeutics to accelerate the development of its lead candidate AP-01 in solid tumors, while strengthening R&D team and increasing the company’s attractiveness towards industrial partners and investors.
